The novel therapy of this peptide represents a exciting advance in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and glucose-dependent https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment